Skip to main content
SpringerLink
Log in

Accelerated access to medicines needs less rhetoric

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pace J, et al. Demands for access to new therapies: are there alternatives to accelerated access? BMJ : 2 Oct 2017. Available from: URL: https://doi.org/10.1136/bmj.j4494

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Accelerated access to medicines needs less rhetoric. PharmacoEcon Outcomes News 788, 1 (2017). https://doi.org/10.1007/s40274-017-4369-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4369-x

Search

Navigation